Skip to content

Polaryx Therapeutics, Inc.

PLYX· NasdaqCore metricsCIK 2075320

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -0.53%
Market cap
$94.21M
49.85M shares
Filings
36
—
—
—
-$3.33M
Q3 2026N/M FY25 yoy
-$3.33M
Q3 2026N/M FY25 yoy
—
—
—
-$0.07
Q3 2026N/M FY25 yoy
$8.44M
Q3 2026+11.3% FY25 yoy
$94.21M
—
—
12.4×
—
—

FY2025 figures · derived

Price

$1.8994.60%$33.11since Feb 2, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$6.27MFY 2025
$6.27M0FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$6,266,000reported
FY 20242024-12-31$2,811,000reported

Pharmaceutical preparations

Polaryx Therapeutics, Inc. is the 290th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Polaryx Therapeutics, Inc. · CIK 2075320 · Engraved from SEC EDGAR